Key statistics
On Friday, CARsgen Therapeutics Holdings Ltd (2171:HKG.HS) closed at 14.40, 52.54% above the 52 week low of 9.44 set on Feb 13, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 13.93 |
|---|---|
| High | 14.40 |
| Low | 13.80 |
| Bid | 14.22 |
| Offer | 14.40 |
| Previous close | 14.00 |
| Average volume | 1.88m |
|---|---|
| Shares outstanding | 570.31m |
| Free float | 352.37m |
| P/E (TTM) | -- |
| Market cap | 7.98bn HKD |
| EPS (TTM) | -1.07 HKD |
Data delayed at least 15 minutes, as of Feb 13 2026 08:08 GMT.
More ▼
Press releases
- CARsgen Signs Strategic Cooperation Agreements to Expand CAR-T Commercial Manufacturing Base in Jinshan, Shanghai
- CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
- CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596
- CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
- CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
- CARsgen's CAR-T Product Zevor-Cel Included in China's Commercial Health Insurance Innovative Drug Catalogue
More ▼
